Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Effects of recombinant Echinococcus granulosus antigen P29 on hematological indicators in sheep.

Created on 11 Jul 2026

Authors

Hanyu Zhang, Yan Huo, Wei Huang, Jing Wang, Wei Zhao, Jihui Yang

Published in

Frontiers in cellular and infection microbiology. Volume 16. Pages 1831004. Epub Jun 26, 2026.

Abstract

This study aimed to evaluate the effects of immunization with recombinant Echinococcus granulosus antigen P29 (rEg.P29) on hematological, physiological, and biochemical indicators in sheep.
A total of 36 4-6-month-old female Ningxia Yanchi Tan sheep, negative for Brucella and echinococcosis antibodies by ELISA, were randomly assigned to four groups (nine sheep per group). Following primary and booster immunizations with rEg.P29, peripheral blood samples were collected at weeks 0 and 20. ELISA, automated hematology analysis, and biochemical analysis were used to assess antigen-specific antibody levels, routine blood parameters, and biochemical indicators. At week 20 post-immunization, all sheep were humanely euthanized, and liver, spleen, and kidney tissues were collected for histopathological examination.
rEg.P29 significantly increased antigen-specific IgG levels at 20 weeks post-immunization compared with baseline. Hematological, biochemical, and histopathological analyses revealed no abnormal changes in blood parameters, physiological metabolism, or tissue morphology of the liver, spleen, and kidney, indicating a favorable safety profile.
rEg.P29 immunization induces a robust humoral immune response without affecting hematopoietic cell homeostasis or liver and kidney function in sheep, as confirmed by hematological, biochemical, and histopathological analyses. These findings demonstrate the immunogenicity and safety of rEg.P29 and support its potential for the development of vaccines against echinococcosis.

PMID:
42434426
Bibliographic data and abstract were imported from PubMed on 11 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement